ClinicalTrials.Veeva

Menu

Treatment of Popliteal Aneurysms With VIABAHN Stent Graft in Elective Surgery (VAP-AURC)

Civil Hospices of Lyon logo

Civil Hospices of Lyon

Status

Unknown

Conditions

Popliteal Aneurysm

Treatments

Device: Endovascular treatment of aneurysms of the popliteal artery by GORE VIABAHN® stent in elective surgery

Study type

Observational

Funder types

Other

Identifiers

NCT03996889
VAP-AURC

Details and patient eligibility

About

This multicentric, prospective study will evaluate the medium-term outcomes of patients implanted with GORE VIABAHN® stent grafts for popliteal artery aneurysms in scheduled elective surgery with the registry of the Research in Vascular Surgery University Association (AURC)

Enrollment

50 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • > 18 years old at time of treatment
  • symptomatic or asymptomatic popliteal artery aneurysm needing surgery
  • scheduled elective surgery

Exclusion criteria

  • life expectancy of <1 year
  • thrombotic occlusion of popliteal artery
  • intolerance to antiplatelet drugs (antiaggregants)
  • known allergies to GORE VIABAHN® stent graft materials/composition
  • emergency surgery

Trial design

50 participants in 1 patient group

Popliteal aneurysm patients with GORE VIABAHN®
Description:
The study population will include all popliteal aneurysm patients treated with GORE VIABAHN® stent graft in scheduled elective surgery, whether symptomatic or asymptomatic.
Treatment:
Device: Endovascular treatment of aneurysms of the popliteal artery by GORE VIABAHN® stent in elective surgery

Trial contacts and locations

1

Loading...

Central trial contact

Nellie DELLA SCHIAVA, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems